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     Although phenotypically polarized macrophages are now generally classified into 
2 major subtypes termed pro-inflammatory M1 and anti-inflammatory M2 macrophages, 
a contributory role of lung M2 macrophages in the pathophysiological features of acute 
lung injury is not fully understood.  Here, we show in an endotoxemic murine model 
that M2 macrophages serve as key anti-inflammatory cells that play a regulatory role in 
the severity of lung injury.  To study whether M2 macrophages can modify 
inflammation, we depleted M2 macrophages from lungs of CD206-diphtheria toxin 
receptor transgenic mice during challenge with lipopolysaccharide.  Intrapenetreal 
administration of diphtheria toxin depleted CD206-positive macrophages in lungs and 
exaggerated lung inflammation, including up-regulation of pro-inflammatory cytokines 
and increased histologic lung damage.  In CD206-diphtheria toxin receptor transgenic 
mice given diphtheria toxin, the endotoxemia-induced increase in NF-κB activity was 
significantly reduced, suggesting that M2 phenotype-dependent counteraction of 
inflammatory insult cannot be attributed to the inhibition of the NF-κB pathway.  In 
contrast, AP-1 c-Jun and c-Fos activities were greatly enhanced in CD206-depleted 
mice with endotoxemia.  These findings demonstrate that pulmonary M2 macrophages 
internally protect against lung inflammation by lessening AP-1 activation and may 
become part of a therapeutic strategy for pulmonary inflammatory disease. 
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     Macrophages are critical regulators of many organ systems, including innate and 
adaptive immunity, systemic metabolism, hematopoiesis, vasculogenesis, malignancy, 
and reproduction.1  Macrophages differentiate into functionally distinct immunological 
populations depending on the microenvironments.  On the basis of Th1/Th2 
polarization concepts,2 phenotypically polarized macrophages are now generally termed 
pro-inflammatory M1 and anti-inflammatory M2.3,4  Macrophages exposed to 
microbial products and IFN-γ become classically activated macrophages (M1), which 
produce copious amounts of pro-inflammatory cytokines and chemokines, keys among 
these are TNF-α, IL-1β, IL-6, IL-12, and CCL-2, as well as reactive oxygen 
intermediates, and function predominantly in inflammation, tissue damage, killing of 
intracellular microbes, and increased tumoricidal activity.3  Recent studies also suggest 
that the phenotypic switching of adipose tissue macrophages from M2 to M1 is 
generated by obesity, leading to systemic inflammation and insulin resistance.5-7  In 
contrast, alternative activation of macrophages is promoted by a variety of stimuli, such 
as IL-4, IL-10, IL-13, and glucocorticoids, that elicit different M2 forms.  M2 
macrophages up-regulate scavenger, mannose receptor, galactose receptor, and IL-1 
receptor antagonist, and down-regulate IL-1β and other pro-inflammatory cytokines.3,8,9  
They are principally able to tune inflammatory responses and adaptive Th2 immunity, 
and to promote tissue remodeling, angiogenesis, and tumor development.3,10  
Furthermore, M2 macrophage activation can protect neuron and facilitate neuronal 
regeneration in Alzheimer’s disease.11  M2-polarized macrophages are further 
subdivided into the wound-healing M2a (elicited by IL-4 and IL-13), the regulatory 
M2b (following stimulation by immune complexes in the presence of Toll-like receptor 
ligands), and the M2c (when exposed to anti-inflammatory stimuli such as 
glucocorticoids, IL-10, and TGF-β),4 but this subclassification may not fully represent 
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the complexity of the transitional states of macrophage activation, which is finely tuned 
in response to different microenvironments.12 
     Acute lung injury (ALI) is a common and highly morbid clinical disease marked 
by respiratory failure attributable to increased pulmonary endothelial and epithelial 
permeability, leading to alveolar flooding, and neutrophil accumulation in alveolar 
spaces and in adjacent capillaries.13,14  Although neutrophil influx and activation 
within the lung play a crucial role in the pathogenesis of ALI,15 growing evidence 
indicates that macrophages also contribute to the modulation of lung inflammation and 
the resultant lung injury.16-18  Several studies have found that macrophage depletion 
with clodronate-lisosomes results in attenuation of lung injury following endotoxin 
administration, ischemia-reperfusion, and mechanical ventilation.19-22  Conversely, 
other studies suggest that the recruitment of macrophages to the lung is associated with 
attenuated lung injury.23,24  One possible explanation for such disparate roles of 
macrophages in ALI may be related to different depletion or recruitment of 
heterogeneous populations of pro-inflammatory and anti-inflammatory macrophages in 
the lung.  However, how M2 macrophages have a protective anti-inflammatory role 
under the pathological condition of ALI are not fully understood. 
     In the present study, we decided to deplete M2 macrophages in mice during 
exposure to lipopolysaccharide (LPS).  We generated a line of transgenic (Tg) mice 
expressing human diphtheria toxin (DT) receptor under the control of the CD206 gene 
promoter.  Murine cells are naturally resistant to DT as they lack functional cell 
surface receptors for the toxin.25-27  Thus, the technique with human DT receptor 
transduction allows us to achieve efficient inducible ablation of a specific type of 
murine cells by DT administration in vivo.  Because CD206 is a cell surface receptor 
as an M2 phenotypic marker, systemic administration of DT was able to lead to a sharp 
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decline in lung M2 macrophages in CD206-DT receptor TG mice.  Here, we identify 
lung M2 macrophages as key anti-inflammatory cells that play a regulatory role in the 
severity of endotoxin-induced lung injury. 
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Materials and Methods 
Generation and Screening of CD206-DT receptor Tg Mice 
We obtained the mouse BAC clone RP 24-377 D19 carrying a 152 kbp insert 
containing the exon coding translational start Met and upstream 133 kbp sequence of 
CD206 gene from the BACPAC Resources Center CHORI (Oakland, CA).  The 
plasmid pTRECK6 that includes noncoding exon and intron from rabbit β-globulin gene, 
human HB-EGF (DT receptor) cDNA, and rabbit β-globulin and simian virus (SV) 40 
polyadenylation (pA) signals was kindly provided by Dr. Kenji Kohno (Nara Institute of 
Science and Technology).28,29  Using a Counter-selection BAC modification kit (Gene 
Bridges, Dresden, Germany), we inserted the noncoding exon and intron from rabbit 
β-globulin gene, human DT receptor cDNA, and rabbit β-globulin and SV 40 pA signals 
at the initiation site of translation in the CD206 gene to yield the pTg-CD206-DT 
receptor (see Figure 1A). 
The purified pTg-CD206-DT receptor BAC DNA was microinjected into 
pronuclei of fertilized one-cell embryos from C57BL/6 mice.  Founder mice were 
crossed with C57BL/6 mice to produce +/CD206DT receptor mice.  The wild type (+/+) 
and heterozygous CD206-DT receptor(+/CD206DTR) littermates were used for analysis. 
All mice were housed in a specific pathogen-free facility.  Experiments were 
performed according to institutional guidelines. 
For the genotyping of the Tg mouse lines by Southern blot analysis, genomic 
DNA prepared from tail biopsy was digested with BamHI, separated by electrophoresis 
on a 0.6 % agarose gel, and transferred to a nylone membrane (Hybond-N+).  
Hybridization was conducted with a 900-bp 32P-labeled DNA fragment derived from the 
exon1 and intron1 (see Figure 1B).  The detected band sizes of endogenous and 
transgenic genes were 8.3 kb and 3.8 kb, respectively. 
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Experimental Procedures 
     In a first series of experiments to examine the effects of M2 macrophage 
depletion under normal non-inflammatory conditions, CD206-DT receptor Tg mice and 
WT littermates received an intraperitoneal injection of 15 µg/kg DT.  Mice were 
administered DT for three consecutive days and were killed 24 h after the last injection 
(see Figure 2A).  Blood samples were collected and various tissues and organs were 
removed.  Some mice were given PBS instead of DT. 
     In another series of experiments to address the role of M2 macrophages in 
endotoxin-induced ALI, mice received an intraperitoneal injection of 15 µg/kg DT for 
three consecutive days and subsequently challenged with intravenous LPS (0.1 mg/kg; 
List Biological Laboratories, Campbell, CA) 24 h after the last injection (see Figure 3A).  
Mice were killed 2 h later, and blood collection and lung tissue isolation were 
performed. 
 
RNA Extraction and Quantitative Real-Time PCR 
Total RNA was isolated from tissues with an RNeasy Mini Kit (Qiagen, Tokyo, 
Japan).  RNA was reverse-transcribed to cDNA, and real-time PCR analyses were 
performed as described previously30 using Takara RNA PCR kit (Takara Bio).  The 
sequences of specific primer pairs for target genes are available upon request from a 
website of Takara Bio Inc. (http://www.takara-bio.co.jp/).  Thermal cycler parameters 
were as follows: 1 cycle of 50oC for 2 min, 50 cycles of denaturation (95oC, 15 s), and 
combined annealing/extension (60oC, 30 s).  Gene expression changes were calculated 
by the comparative Ct method, and 18S ribosomal RNA was used as reference genes for 
normalization. 
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Enzyme Immunoassay for Cytokines 
     Blood levels of IL-1β, TNF-α, MCP-1, and IL-6 were measured by the use of 
commercially available enzyme-linked immunosorbent assay kit (R&D Systems, 
Minneapolis, MN) according to the manufacture’s instructions.  The plate was read on 
a microplate reader (Nippon-InterMed, Tokyo, Japan).  Assays were performed in 
duplicate. 
 
Histologic Examination 
     For routine histology, inflation-fixed lungs were harvested, fixed, dehydrated, 
paraffin-embedded, and sliced into 4-µm-thick sections.30,31  After deparaffinization, 
slides were stained with hematoxylin and esosin using standard methods.  A 
semiquantitative morphometric analysis of lung injury was performed by scoring from 0 
to 4 (none, light, moderate, severe, very severe) for the following categories: neutrophil 
infiltration, pulmonary edema, and disorganization of lung parenchyma and 
hemorrhage.30  A total lung injury score was calculated by adding the individual scores 
in every animal and averaging the total values in each group.  All the histological 
studies were performed in a blinded fashion. 
 
Immunohistochemistry 
     Five-mm-thick frozen lung sections were fixed in acetone for 10 min at -20oC and 
air-dried.  Bronchoalveolar lavage (BAL) was performed with five aliquots of 5 ml of 
PBS instilled into the lungs and gently withdrawn.  Cells obtained from the total BAL 
fluid (BALF) were spun at 113 g for 10 min onto glass slides by use of a Cytospin 4 
(Thermo Fisher Scientific, Yokohama Japan).  Then, they were fixed with 4% buffered 
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formalin solution for 10 min at room temperature.  Endogenous peroxidase activity 
was quenched by incubation in 0.3% hydrogen peroxide for 15 min.  After incubation 
overnight at 4oC with anti-CD206 antibody (AbD Serotec, Raleigh, NC, USA), the 
samples were exposed to anti-rat igG conjugated with horseradish peroxidase.  Bound 
antibody was visualized by a light microscopy with diaminobenzidine.  Omission of 
primary antibody and staining with non-immune IgG served as negative control. 
 
NF-κB and AP-1 Binding Assays 
     TransAM NF-κB and TransAM AP-1 kits (Active Motif, Carlsbad, CA) were 
used to quantify the binding of p65 to the NF-κB site and c-Jun and c-Fos to the AP-1 
site, according to the manufacture’s instructions. 
 
Statistical Analysis 
     Data were analyzed by the use of Prism software (ver. 6; GraphPad Software, San 
Diego, CA).  Statistical analysis was performed by one-way analysis of variance 
followed by Tukey’s multiple comparison test.  Differences were considered 
significant at P≤0.05.  Data are presented as means ± SEM.   
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Results 
CD206-Positive Cell Expression and Distribution in Mice 
     CD206 mRNAs were transcribed in a variety of tissues, including lung, liver, 
spleen, and kidney, of normal C57BL/6 mice, but they were most abundant in lung 
tissues (Figure 1C).  Immunohistochemical studies showed that CD206-positive cells 
were present in the alveoli (Figure 1D) and constituted a great portion of the whole cells 
in BALF (Figure 1E). 
 
DT Treatment of CD206-DT Receptor Tg Mice 
     DT treatment resulted in a sharp reduction in CD206 mRNA levels in lungs of 
CD206-DT receptor Tg mice without a significant change in those of WT mice (Figure 
2B).  In line with the effect on CD206 mRNA in lung tissues, DT treatment caused a 
marked decrease in the number of CD206-positive cells in BALF from the CD206-DT 
receptor Tg animal as compared with WT (Figure 2C and D).  DT treatment did not 
substantially affect mRNA levels of pro-inflammatory cytokines, IL-1β, TNF-α, MCP-1, 
and IL-6 in lungs of WT mice.  However, CD206-DT receptor Tg mice exhibited 
up-regulation of these pro-inflammatory cytokine mRNAs in response to DT treatment 
(Figure 2E).  When blood levels of pro-inflammatory cytokines were measured via an 
enzyme-linked immunosorbent assay, the WT animals had very low levels of the 
cytokines examined here regardless of whether DT was given.  In contrast, IL-1β, 
MCP-1, and IL-6 showed an evident increase in CD206-DT receptor Tg mice when 
treated with DT, except that TNF-α was undetectable even though DT was administered 
(Figure 2F). 
 
Effect of LPS in DT-Treated CD206-DT Receptor Tg Mice 
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     When a low dose (0.1 mg/kg) of LPS was intravenously injected, lung CD206 
mRNA levels were significantly decreased in DT-treated WT mice.  The reduction in 
CD206 mRNA in lungs was more marked in DT-treated CD206-DT receptor Tg mice 
(Figure 3B). 
     LPS challenge led to up-regulation of IL-1β, TNF-α, MCP-1, and IL-6 mRNA 
levels in lungs of WT mice.  This up-regulation was strikingly enhanced in DT-treated 
CD206-DT receptor Tg mice (Figure 3C).  The ability of LPS at 0.1 mg/kg to 
up-regulate blood levels of TNF-α, MCP-1, and IL-6 was less pronounced in WT mice 
regardless of treatment with DT, although IL-1β responded relatively well to LPS.  
However, LPS caused a significant and substantial impact on all pro-inflammatory 
cytokines examined here in DT-treated CD206-DT receptor Tg mice (Figure 3D). 
     Histologic examination of hematoxylin and eosin-stained sections of the lungs 
revealed that WT mice had alveolar septae that were normal in appearance, with no 
intra-alveolar inflammation (Figure 4A).  Lung histopathology of WT mice given LPS 
showed modest inflammatory cell infiltrate (Figure 4B).  DT-treated CD206-DT 
receptor Tg mice that received LPS had massive cell infiltration, hemorrhage resulting 
from ruptured capillary vessels, and diffuse septal edema (Figure 4C).  
Semiquantitative assessment using lung injury score demonstrated that the score was 
dramatically increased when DT-treated CD206-DT receptor Tg mice was challenged 
with LPS (Figure 4D). 
     To examine the activation of the pro-inflammatory transcription factor NF-κB in 
lungs after LPS challenge, NF-κB DNA binding activity was measured in nuclear 
protein extracts from lungs.  The DNA binding activity of NF-κB was greatly 
increased in WT mice following LPS injection.  This increase was significantly 
attenuated in DT-treated CD206-DT receptor Tg mice (Figure 5A).  Another 
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pro-inflammatory transcription factor AP-1 consists of Jun family and Fos family 
proteins.  Thus, c-Jun and c-Fos proto-oncogenes encode proteins that form a complex 
which regulates transcription from promoters containing AP-1 activation elements.32  
Both c-Jun and c-Fos binding activities were significantly increased when WT mice 
were challenged with LPS.  Further rises in these binding activities in response to LPS 
were observed in DT-treated CD206-DT receptor Tg mice (Figure 5B and C). 
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Discussion 
     The concept of macrophages existing in functionally distinct phenotypes from 
pro- to anti-inflammatory states has been fully established by detailed studies on M1 
and M2 macrophages.3,4,8,9  A growing body of evidence is accumulating that 
macrophages are key regulators of the induction and resolution phases of ALI, 
suggesting distinct roles of macrophage subpopulations.33  Understanding this 
heterogeneity of pulmonary macrophages may be important in developing strategies to 
modulate ALI.  However, there is no direct evidence that pulmonary M2 macrophages 
make a significant contribution to the pathophysiological features of ALI.  In this work, 
we addressed this issue by studying how depletion of M2 macrophages can modify lung 
inflammation in endotoxemic mice. 
     CD206 encodes the mannose receptor C-type lectin, a cell surface protein that 
belongs to a family of C-type lectin receptors.34  This endocytic receptor is known to 
be expressed on macrophages and probably other types of cells, including airway 
smooth muscle cells.35-38  The expression of the receptor is highly regulated and 
correlates with the functional state of macrophages.  Thus, fully mature activated M2 
macrophages express CD206 as a phenotypic hallmark.39  Therefore, CD206 can be 
widely used to identify the M2 phenotype.3  In the present study, DT administration on 
CD206-DT receptor Tg mice led to conditional CD206-positive cell ablation, which 
implies that M2 macrophages were effectively depleted in vivo. 
     A significant number of M2 macrophages were found in the BALF of C57BL/6 
mice under normal conditions.  Lung sections from normal C57BL/6 mice showed that 
M2 macrophages were also detected in the alveoli.  DT-mediated M2 macrophage 
depletion in CD206-DT receptor Tg mice demonstrated that mRNA levels of 
pro-inflammatory cytokines, IL-1β, TNF-α, MCP-1, and IL-6, were up-regulated in 
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lungs.  We interpret these observations to indicate that M2 macrophages lead to a tonic 
inhibition of pulmonary production of pro-inflammatory cytokines.  Blood levels of 
IL-1β, MCP-1, and IL-6 were apparently increased when abolition of M2 macrophages 
was made by administration of DT to CD206-DT receptor Tg mice.  This suggests that 
M2 macrophage-mediated tonic inhibition of the genesis of pro-inflammatory cytokines 
under basal sub-inflammatory conditions may be found systemically. 
     Administration of LPS at a low dose resulted in a significant reduction in 
expression of CD206 mRNA in mouse lungs, suggesting that M2 macrophages may be 
down-regulated by a low dose of LPS.  In agreement with this finding, a recent report 
has shown that low doses of LPS can effectively suppress expression of the M2 marker 
arginase-1 when bone marrow-derived macrophages were treated with M2 skewing 
mediators.40  Alternatively, M2 macrophages may be transformed into M1 
macrophages following LPS stimulation to promote inflammation.  Despite low levels 
of M2 macrophages under endotoxemic conditions, the presence of M2 macrophages 
appears to be important in the regulation of the inflammatory state during endotoxemia.  
DT-mediated depletion of M2 macrophages in CD206-DT receptor Tg mice led to a 
discernible enhancement of the LPS-induced increases in pulmonary mRNA levels of 
pro-inflammatory cytokines.  Furthermore, this manipulation significantly aggravated 
LPS-induced lung injury.  These results suggest that M2 macrophages serve as a 
protective phenotype and can lessen lung inflammation during endotoxemia.  DT 
treatment accelerated the deleterious effect of LPS on blood pro-inflammatory cytokine 
levels in CD206-DT receptor Tg mice, implying that M2 macrophages appear essential 
for appropriate moderation of systemic endotoxemic inflammation. 
     In quiescent cells, NF-κB is maintained in inactive form by IκB.41  LPS 
stimulates IκB-kinase (IKK) that specifically phosphorylates IκB, resulting in IκB 
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polyubiquitination and subsequent degradation, followed by liberation of NF-κB.42  
Many M1 genes have κB sites in their promoter region, including iNOS and COX-2.43  
Thus, in M1 macrophages, NF-κB orchestrates the expression of many 
pro-inflammatory genes in response to LPS.  In this study, we showed that M2 
macrophage depletion resulted in a significant reduction in LPS-induced NF-κB activity, 
suggesting that M2 phenotype-dependent counteraction of inflammatory insult cannot 
be attributed to the inhibition of the NF-κB pathway.  At the present time, however, we 
do not have a clear understanding of whether the reduced NF-κB activity was the result 
of the critical regulation of the transcription factor by M2 macrophages.  Another 
major pro-inflammatory transcription pathway within macrophages involves the AP-1 
pathway whose pro-inflammatory targets overlap those of the NF-κB pathway.44  AP-1 
is a group of a basic leucine zipper transcription factors, including the Fos and Jun 
families of transcription factors.44  We found that AP-1 c-Jun and c-Fos activities were 
greatly enhanced when DT was given to CD206-DT receptor Tg mice with endotoxemia, 
which implies that M2 macrophages negatively regulate the AP-1 pathway.  We thus 
suggest that AP-1 signaling is a key transcriptional regulator involved in the inhibitory 
modulation of lung inflammation by M2 macrophages.  There were slight differences 
in the extents of the enhancing effect of DT treatment on an array of pro-inflammatory 
cytokine levels in CD206-DT receptor Tg mice.  This may be associated with some 
differences in the dependence of the transcription of cytokines on the NF-κB and AP-1 
pathways. 
     We have previously demonstrated that short-term treatment with high doses of 
statin can increase the number of alveolar macrophages in mouse lungs.45  These 
alveolar macrophages display an unusual phenotype compared with typical tissue 
macrophages.  Thus, we have found that alveolar macrophages express high levels of 
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CD11c,45  a molecule that is not expressed by their counterparts in other body sites and 
is generally expressed by dendritic cells.46  However, contrary to dendritic cells, 
alveolar macrophages are very unlikely to emigrate from the tissue and seem to have 
distinct roles in the initiation and maintenance of immune response.47  These alveolar 
macrophages may be now identified as M2 macrophages.  It is noteworthy that our 
statin treatment has been able to mitigate acute lung injury and improve the survival of 
mice with cecal ligation and puncture-induced sepsis.45 
     In conclusion, our findings identify lung CD206-positive M2 macrophages as key 
anti-inflammatory cells during endotoxemic lung injury.  We demonstrate that 
pulmonary M2 macrophages internally protect against lung inflammation by lessening 
AP-1 activation and may become part of a therapeutic strategy for pulmonary 
inflammatory disease. 
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Figure Legends 
Figure 1 CD206 expression in C57BL/6 mice.  A: Schematic representation of 
wild-type (WT) and DT receptor-inserted transgene in BAC DNA(pTg-CD206-DT 
receptor). Exons 1 through 3 of CD206 gene are indicated by open box.  Met is the 
initiation site of translation in CD206. In the pTg-CD206-DT receptor BAC DNA, 
rabbit β-globin intron, human DT receptor cDNA and rabbit β-globin/SV40 poly A 
signals (pA) are indicated by line and gray box.  The probe used for Southern blot 
analysis is indicated as a solid line together with the predicted hybridizing fragments.  
After insertion of DT receptor, the CD206 of the transgene is not expressed.  B: 
Southern blot analysis of BamHI-digested genomic DNA from CD206-DT receptor Tg 
mice.  Genomic DNAs were hybridized with the CD206 probe, as shown in A.  
Location of WT (8.6 kbp), and CD206-transgene (Tg, 3.8 kbp)-derived bands are shown. 
The positions of DNA size markers (kbp) are indicated on the left.  C: CD206 mRNA 
expression in different tissues of normal mice.  The data are expressed as a fold 
increase above kidney value normalized 18 S.  Values are means ± SEM (n = 3 mice). 
*P<0.05, **P<0.01, ***P<0.001.  D and E: Immunohistochemical detection of 
CD206-positive cells in lung sections (D) and in BALF (E) from normal mice.  Lung 
sections and BALF were stained with hematoxylin.  Shown are representative 
micrographs from two independent experiments.  In D, arrows indicate 
CD206-positive cells. 
 
Figure 2 DT treatment on CD206 expression and pro-inflammatory cytokine production 
in CD206-DT receptor Tg mice.  A: Experimental protocol.  Mice were administered 
DT (or PBS) once daily for 3 days.  The animals were then sacrificed 24 h after the last 
DT injection.  B: CD206 mRNA expression in lung tissues.  The data are expressed 
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as a fold increase above WT PBS normalized to 18 S.  C and D: Immunohistochemical 
detection of CD206-positive cells in BALF from WT mice (C) and from DT-treated 
CD206-DT receptor Tg mice (D).  Shown are representative micrographs from two 
independent experiments.  E: mRNA levels of cytokines in lungs.  The data are 
expressed as a fold increase above WT normalized 18 S.  F: Blood levels of cytokines.  
B, E, and F: Values are means ± SEM (n = 7-8 mice).  *P<0.05, **P<0.01, 
***P<0.001 
 
Figure 3 DT treatment on CD206 expression and pro-inflammatory cytokine production 
in CD206-DT receptor Tg mice exposed to LPS.  A: Experimental protocol.  Mice 
were administered DT once daily for 3 days.  The animals then received an 
intravenous injection of LPS 24 after the last DT treatment and were sacrificed 2 h later.  
B: CD206 mRNA expression in lung tissues of mice given LPS.  C: Effect of LPS 
challenge on mRNA levels of cytokines in lungs.  B and C: The data are expressed as a 
fold increase above control WT normalized 18 S.  D: Effect of LPS challenge on blood 
levels of cytokines.  B-D: Values are means ± SEM (n =5-10 mice).  *P<0.05, 
**P<0.01, ***P<0.001. 
 
Figure 4 Lung sections stained with hematoxylin and eosin.  A: Control WT mice.  
B: DT-treated WT mice who received LPS.  C: DT-treated CD206-DT receptor Tg 
mice who received LPS.  D: Semiquantitative analysis of lung tissues by lung injury 
score.  Values are means ± SEM (n = 5-7).  ***P<0.001. 
 
Figure 5 Activation of pro-inflammatory transcriptional factors in lungs of DT-treated 
WT and CD206-DT receptor Tg mice who were challenged with LPS.  A: NF-κB p65 
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DNA binding activity.  B: AP-1 c-Jun DNA binding activity.  C: AP-1 c-Fos DNA 
binding activity.  Values are means ± SEM (n = 5-7 mice).  *P<0.05, **P<0.01, 
***P<0.001. 
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